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Lifelong maintenance of the blood system requires
equilibrium between clearance of damaged hemato-
poietic stem cells (HSCs) and long-term survival of
the HSC pool. Severe perturbations of cellular ho-
meostasis result in rapid HSC loss to maintain clonal
purity. However, normal homeostatic processes can
also generate lower-level stress; how HSCs survive
these conditions remains unknown. Here we show
that the integrated stress response (ISR) is uniquely
active in HSCs and facilitates their persistence. Acti-
vating transcription factor 4 (ATF4) mediates the ISR
and is highly expressed in HSCs due to scarcity of the
eIF2 translation initiation complex. Amino acid depri-
vation results in eIF2a phosphorylation-dependent
upregulation of ATF4, promoting HSC survival. Prim-
itive acute myeloid leukemia (AML) cells also display
eIF2 scarcity and ISR activity marks leukemia stem
cells (LSCs) in primary AML samples. These findings
identify a link between the ISR and stem cell survival
in the normal and leukemic contexts.
INTRODUCTION
Replenishment of the blood system throughout the lifetime of an
organism requires longevity and integrity of the stem cell pool.
However, human HSCs are sensitive to perturbations of cellular
homeostasis and prone to undergo apoptosis. The induction of
reactive oxygen species (ROS) and accumulation of DNA dam-
age leads to heightened apoptosis of HSCs compared to down-
stream progenitor cells (Milyavsky et al., 2010; Yahata et al.,
2011). Likewise, endoplasmic reticulum (ER) stress causes
strong activation of the unfolded protein response in HSCs, re-
sulting in increased apoptosis compared to progenitor cells (Mi-Cell Rep
This is an open access article under the CC BY-Nharada et al., 2014; van Galen et al., 2014a). These responses
promote stem cell pool integrity by purging damaged stem cells,
but to ensure longevity, HSCs also must be able to survive per-
turbations that regularly occur during homeostasis such as DNA
damage and calorie restriction (Ho et al., 2017; Warr et al., 2013).
The signals that ensure persistence of HSCs in the context of
lower-level stress caused bymetabolic processes during normal
homeostasis are unknown.
Many stressors converge on the ISR pathway. This pathway
serves to balance stress signals that activate cell death path-
ways with those that protect the cell to enable restoration of
cellular homeostasis (Pakos-Zebrucka et al., 2016). In low-stress
conditions, the ISR favors survival as a consequence of the
intrinsic stability of adaptive mRNAs and proteins, whereas
high stress levels tip the balance toward distal ISR targets that
promote cell death (Han et al., 2013; Rutkowski et al., 2006).
This survival-death equilibrium is maintained by four stress-
inducible kinases: GCN2, PKR, HRI, and PERK (Figure 1A).
These kinases phosphorylate eIF2a, a subunit of the eIF2 com-
plex (consisting of eIF2a, b, and g), thereby preventing formation
of the ternary complex (eIF2, GTP, and Met-tRNAi) (Aitken and
Lorsch, 2012). This leads to attenuation of global translation
initiation, which conserves amino acid pools for essential
cellular functions, relieves chaperones of their load, and lowers
metabolic demands associated with protein synthesis (Wek
et al., 2006). Thus, the ISR integrates many different stressors
and initiates global translational attenuation as a protective
mechanism.
Highly regulated translation dynamics are critical for HSCs,
and recent studies revealed the importance of ribosomal pro-
teins and translation factors to maintain stem cell self-renewal
and lineage commitment (Blanco et al., 2016; Cai et al., 2015;
Khajuria et al., 2018; Signer et al., 2014, 2016). The ISR delays
translation initiation through eIF2a phosphorylation. Paradoxi-
cally, ISR-induced eIF2a phosphorylation increases translation
of specific transcription factors including activating transcription
factor 4 (ATF4), ATF5, and CHOP (DDIT3), with ATF4 being theorts 25, 1109–1117, October 30, 2018 ª 2018 The Author(s). 1109
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. High Integrated Stress Response Activity in HSC/MPPs Compared to Progenitors
(A) Graphic depicts activation of eIF2 translation initiation complex (consisting of a-, b-, and g-subunits) by GDP/GTP exchange, resulting in assembly of the
ternary complex (eIF2, GTP, and Met-tRNAi). In contrast, activation of stress-responsive eIF2a kinases leads to global translational attenuation and upregulation
of ATF4 and downstream stress response factors.
(B and C) Heatmaps show protein detection by label-free mass spectrometry in (B) HSC/MPP and progenitor cells or (C) highly purified Lin– CB populations. Data
for n = 3 biological replicates are shown. Colors indicate normalized protein quantities (log2 and centered). The p values indicate comparison between (B) HSC/
MPP and progenitor cells or between (C) HSC and GMP.
(D) Immunohistochemistry images and analysis show detection of total eIF2a in HSC/MPP (n = 139) and progenitor (n = 163) cells, and P-eIF2a in HSC/MPP
(n = 59) and progenitor (n = 151) cells. Scale bar, 40 mm. Error bars indicate mean ± SD.
(E) Bar graph indicates ATF4 mRNA expression in sorted CB populations. Dashed blue line indicates the 80th percentile of 29,331 microarray probes (Laurenti
et al., 2013). Log2 values of three ATF4mRNA probes are shown as mean ± SD, equalized for HSC1 detection. The p value indicates higher ATF4 expression in
primitive cells.
(F) Heatmap shows expression of ATF4 target genes that are differentially expressed between HSC/MPP (HSC1, HSC2, MPP) andmyeloid progenitor cells (CMP,
GMP, MEP, p < 0.01; see STAR Methods). Microarray values are log2 transformed and centered (Laurenti et al., 2013).
(G) Gene set enrichment analysis shows ATF4 targets from (F) in a gene list ranked by the fold difference between HSC/MPP and myeloid progenitor cells.
*p < 0.05, ****p < 0.0001. See also Table S1 and Figure S1.most direct ISR effector (Pakos-Zebrucka et al., 2016). Mecha-
nistically, ternary complex scarcity leads to ribosomal bypass
of an inhibitory upstream open reading frame (uORF) in the1110 Cell Reports 25, 1109–1117, October 30, 2018ATF4mRNA, leading to efficient ATF4 translation and protein up-
regulation (Lu et al., 2004). Transcriptional targets of ATF4
include regulators of amino acid metabolism, redox balance,
autophagy, and protein synthesis (B’chir et al., 2013; Han et al.,
2013; Harding et al., 2003). Thus, ISR activation results in effi-
cient translation of ATF4, which in turn activates gene networks
to facilitate restoration of cellular homeostasis.
The ISR regulates cellular homeostasis in various tissues and
cancer cells, but it has typically been studied in bulk populations.
Whether the ISR plays distinct roles within the individual cells
that make up a tissue hierarchy like the hematopoietic system
is unknown. Bymonitoring ATF4 activity in normal andmalignant
blood cells, we show that the pro-survival ISR pathway is integral
to modulating stem cell stress responses.
RESULTS
High Integrated Stress Response Activity in HSC/MPPs
Compared to Progenitors
To assess the expression levels of key ISR pathway compo-
nents, we analyzed the proteome of purified human HSCs and
progenitor cells. Quantitative label-free mass spectrometry re-
vealed lower protein levels of eIF2a, eIF2b, and eIF2g in HSC/
MPPs (multipotent progenitors) compared to downstream pro-
genitors (Figure 1B; Table S1) (E.M.S., S. Xie, A. Mitchell, K.B.
Kaufmann, Y. Ge, E. Lechman, T. Kislinger, B.T. Porse, J.E.D.,
unpublished data). Analysis of more highly purified HSC and pro-
genitor populations showed that eIF2 subunits are similarly
expressed in HSCs, MPPs, and multilymphoid progenitors
(MLPs), but upregulated in downstream granulocyte-macro-
phage progenitors (GMPs) (Figure 1C), which is also seen
in mouse hematopoiesis (Klimmeck et al., 2012; Signer
et al., 2014). To assess levels of total and phosphorylated
eIF2a (P-eIF2a), we used immunohistochemistry and intracel-
lular flow cytometry. Within the progenitor compartment, we
observed heterogeneity with low and high expression of eIF2a,
which may represent different levels within committed progeni-
tor cells of the erythroid, myeloid, and lymphoid lineages. In
HSC/MPPs, levels of eIF2a and P-eIF2a were lower on average
than in progenitors (Figure 1D; Figures S1A–S1C). The eIF2a ki-
nase PKR was lower in HSC/MPPs compared to progenitors,
whereas GCN2 showed an opposite trend (Figure S1D). These
data show that key ISR components are distinctly regulated
within the hematopoietic hierarchy and that eIF2a, b, and g pro-
tein levels are low in HSC/MPPs.
Low eIF2-GTP-Met-tRNAi ternary complex leads to efficient
translation of ATF4, the principal transcription factor that acti-
vates ISR target genes. To gain more insight into ATF4 regulation
and activity in HSCs and progenitor cells, we used gene expres-
sion data from sorted stem and progenitor cell populations from
lineage-depleted cord blood (lin– CB) (Laurenti et al., 2013).ATF4
mRNA is highly expressed in CB progenitor cells (mean detec-
tion of three ATF4 probes is in the top 20% of 29,331 probes).
Furthermore,ATF4 expression is higher in HSC/MPPs compared
to progenitors, consistent with previous qPCR results (van Galen
et al., 2014a) (Figure 1E). Of the 225 recently identified ATF4
target genes (Han et al., 2013), 54 were differentially expressed
between HSC/MPP and myeloid progenitor cells (Figure 1F;
STAR Methods). Gene set enrichment analysis showed that
this set of 54 ATF4 target genes is significantly enriched in
HSC/MPPs compared to progenitor cells (false discovery rate[FDR] < 0.001; Figure 1G), suggesting that ATF4 is active in
HSCs and contributes to the transcriptional activation of ISR
target genes.
ATF4 Reporter Measures ISR Activation
Tomonitor ATF4 translation, we utilized a lentiviral ATF4 reporter
(ATF4rep) that increases translation of an ATF4-GFP fusion gene
under conditions of stress that result in eIF2a phosphorylation
(Figure S2A) (van Galen et al., 2014a). To determine the speci-
ficity of the ATF4rep to different kinds of stress, we transduced
TLS-ERG-immortalized cord blood cells (TEX cells) with the
ATF4rep and treated them with various stressors. As expected,
the ER stress agent thapsigargin, which is commonly used to
induce eIF2a phosphorylation, increased ATF4rep 2.1-fold, as
measured by the transgene ratio (TGR) between GFP and
TagBFP (Figure 2A; STAR Methods). In contrast, bortezomib,
which disrupts proteostasis but is not known to function through
the ISR, did not cause a notable increase of the ATF4rep TGR.
Similarly, the mTOR inhibitor temsirolimus, the translation elon-
gation inhibitor cycloheximide, and the histone deacetylase in-
hibitor valproic acid did not induce ATF4rep, despite having an
impact on cell viability (Figure S2B). Negative and positive con-
trol vectors showed no change of the ATF4rep TGR (Figures
S2C and S2D). Collectively, these results indicate that the
ATF4rep is efficiently induced by ISR activation but not by
stressors that are independent of the ISR.
To assess the functionality of the ATF4rep in primary human
blood stem and progenitor cells, we transduced lin– CB cells
with the ATF4rep and assessed ATF4 protein levels in sorted
GFP-high and GFP-low cells (Figure 2B). ATF4 protein levels
were higher in GFP-high cells, indicating that GFP provides a
measure for the level of endogenous ATF4. We previously
showed that severe tunicamycin-induced ER stress activates
the ATF4rep in lin– CB cells (van Galen et al., 2014a). Other con-
ditions, such as oxidative stress or amino acid deprivation, may
lead to less severe stress in the native environment of HSCs. We
subjected ATF4rep-transduced CD34+ CB cells to hypoxia and
valine depletion, the latter of which strongly induced ATF4rep
activation (Figure 2C). More broadly, depletion of 13 amino acids
induced the ATF4rep in lin– CB cells (Figure 2D). Thus, amino acid
deprivation strongly induces ISR activation and ATF4 translation
in primitive human CB cells.
ATF4 Upregulation through eIF2a Phosphorylation
Promotes CB Cell Survival
Phosphorylation of eIF2a reduces ternary complex availability
and increases ATF4 levels because slow translation reinitiation
favors the ATF4ORF instead of the inhibitory uORF2 (Figure S2A)
(Lu et al., 2004). To investigate whether ATF4rep activation
following valine depletion depends on eIF2a phosphorylation,
we transduced CD34+ CB cells with overexpression vectors of
wild-type eIF2a and eIF2aS52A, a mutant protein that cannot be
inactivated by phosphorylation. Following overexpression of
wild-type eIF2a, valine depletion resulted in strong ATF4rep acti-
vation in CD34+ CB cells (10-fold TGR increase; Figure 2E). In
contrast, overexpression of eIF2aS52A abolished valine deple-
tion-induced activation of the ATF4rep, indicating that eIF2a
phosphorylation is responsible for ATF4 upregulation followingCell Reports 25, 1109–1117, October 30, 2018 1111
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Figure 2. ISR Activates the ATF4 Reporter and Protects against Valine Depletion
(A) Bar plots show TGR of ATF4rep-transduced TEX cells that were treated with indicated stressors. Data are shown as mean ± SD of n = 2 technical replicates,
representative of n = 3 similar experiments.
(B) Western blot shows ATF4 levels in sorted GFP-low and GFP-high ATF4rep-transduced lin– CB cells that were treated with thapsigargin. GAPDH is the loading
control. Results are representative of n = 2 CB samples.
(C) Bar plots shows ATF4rep TGR of transduced CD34+ CB cells that were cultured in hypoxic conditions or valine deficient media. Data are shown as mean ± SD
of n = 2 CB samples.
(D) Bar plot shows ATF4rep TGR of transduced lin– CB cells that were cultured in complete (full) medium or media depleted of individual amino acids. Data are
shown as mean ± SD of n = 3 time points. Flow cytometry histograms show GFP intensity of TagBFP+ cells at indicated conditions. Letters indicate which amino
acid is removed; ’ indicates hydrochloride.
(E) Bar plot shows TGR of ATF4rep-transducedCD34+ CB cells that were co-transduced for overexpression of wild-type eIF2a or eIF2aS52A (marked bymOrange).
Data are shown as mean ± SD of n = 3 CB samples. Representative histograms show GFP intensity of mOrange+TagBFP+ CB cells.
(F) Bar plot shows TGR of ATF4rep-transducedCD34+ CB cells that were co-transducedwith shRNAs for eIF2S1, eIF2S2, or eIF2S3 (marked bymCherry). ATF4rep
TGR of mCherry+TagBFP+ cells is shown as mean ± SD for n = 3 CB samples.
(G andH) Bar plots show cell proliferation (G) and apoptosis (H) of CD34+ CB cells that were transduced with shATF4 vectors and cultured without valine. Data are
shown as mean ± SD of n = 4 CB samples.
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure S2.
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Figure 3. Human HSC/MPPs Display High ISR Activity under Basal Conditions
(A) Bar plot shows ATF4rep TGR of CB cells, 4 days after sorting and transduction. TagBFP-only cells were transduced with a vector lacking the ATF4-GFP
transgene. Data are shown as mean ± SEM of n = 4 CB samples. Representative histogram shows GFP intensity of TagBFP+ cells.
(B and C) Scatter column plots show ATF4rep TGR in CB cell populations, isolated from engrafted mice. (B) Each symbol represents the BM of one mouse. Data
from n = 2 CB samples are normalized to CD33+ cells. (C) Each symbol represents one BM pool, combined from several mice, for n = 3 CB samples. The p values
indicate comparisons to HSC/MPP fractions. Error bars indicate mean ± SD.
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are shown (same as in D).
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. See also Figure S3.valine depletion. Knockdown of eIF2a, eIF2b, or eIF2g increased
ATF4rep activity (Figure S2E; Figure 2F), indicating that eIF2 avail-
ability regulates ATF4 translation. These data establish that
valine depletion leads to eIF2a phosphorylation, which reduces
ternary complex availability resulting in efficient ATF4 translation.
ATF4 upregulation can induce an adaptive response to diverse
stimuli such as oxidative stress, whereas the same pathway can
induce apoptosis following severe or prolonged stress (Pakos-
Zebrucka et al., 2016). To assess the effect of ATF4 upregulation
on survival of CB cells undergoing valine deprivation, we used
short hairpin RNA (shRNA) to knock down ATF4 transcript levels
(Figure S2F). Following knockdown of ATF4 in CD34+ CB cells,
the cells were incubated in valine deficient media to induce
translational upregulation of ATF4. Valine depletion of non-tar-
geting short hairpin RNA (shCTRL)-transduced cells for 2 days
did not affect proliferation or apoptosis, as measured by
EdU incorporation and Annexin-V (Figures 2G and 2H). In
contrast, valine depletion of shATF4-transduced cells resulted
in decreased proliferation (2-fold, p = 0.0004; Figure 2G) and
increased apoptosis (4-fold, p < 0.0001; Figure 2H). Thus,
ATF4 promotes cell survival of primitive CD34+ CB cells under-
going valine depletion.
Human HSC/MPPs Display High ISR Activity under Basal
Conditions
To assess ISR activity across the human hematopoietic hierar-
chy, we sorted CD34+CD38– HSC/MPPs and CD34+CD38+ pro-genitors from lin– CB and transduced them with the ATF4rep.
After 4 days in culture, ATF4rep TGR was 1.6-fold higher in
HSC/MPPs compared to progenitors (Figure 3A; Figure S3A),
indicating that HSC/MPPs have high ISR activity compared to
committed progenitors in vitro. Since in vitro culture could induce
stress, we sought to undertake in vivo xenograft studies to
examine HSC/MPP and progenitors in the best available setting
to approximate homeostatic conditions for human cells. Trans-
plantation of ATF4rep-transduced lin– CB cells showed that hu-
man HSC/MPPs in the mouse bone marrow (BM) maintained a
2.4-fold higher ATF4rep TGR compared to downstream progen-
itors (Figure 3B). Furthermore, HSC/MPPs displayed a 2.3-fold
higher ATF4rep TGR in comparison to closely related MLPs (Fig-
ure 3C). ATF4rep TGR further declined in downstream common
myeloid progenitor and megakaryocyte-erythroid progenitor
(CMP and MEP) populations and, compared to HSC/MPPs,
was 13-fold lower within mature monocytes, granulocytes,
pro-B, and B cells (Figure 3C). These results indicate that
HSCs display higher ISR activity than progenitors when as-
sessed in basal conditions, which may contribute to HSC
endurance.
To determine if the high ISR activity in HSCs is associated with
improved survival, we transplanted lin– CB cells expressing high
ATF4rep activity (GFP-high) and low ATF4rep activity (GFP-low)
into mice (Figure S3B). The level of engraftment from GFP-high
cells was increased compared to GFP-low cells (Figure 3D).
Furthermore, the number of engrafted mice from GFP-high cellsCell Reports 25, 1109–1117, October 30, 2018 1113
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Figure 4. Enrichment of Human LSCs
Based on High ISR Levels
(A) Heatmaps show protein detection by label-free
mass spectrometry in sorted CD34+CD38– and
CD34+CD38+ cells from 11 AML patients. Some
fractions are not tested because we could not
obtain a sufficient number of cells to performmass
spectrometry. Colors indicate normalized protein
quantities (log2 and centered).
(B) Gene set enrichment analysis shows ATF4
targets (from Figure 1F) in a gene list ranked by
the fold difference between sorted CD34+CD38–
and CD34+CD38+ AML cells. mRNA expression in
AML fractions was previously assessed by RNA
sequencing (RNA-seq) (Ng et al., 2016).
(C) Flow histogram shows GFP intensity of primi-
tive (CD34+) and differentiated (CD34–) ATF4rep-
transduced TagBFP+ 8227 cells. Results are
representative of n = 2 independent experiments.
(D) Line graph shows population doublings of
sorted 8227 cells. Viable cells were counted at
6-day intervals. Data are shown as mean ± SD of
n = 3 technical replicates.
(E) Graphic overview of experiment to assess
ATF4rep TGR in AMLCD34/CD38 populations, and
secondary transplantation to assess LSC potential
of GFP-low and GFP-high AML cells.
(F) Line graph shows ATF4rep TGR in phenotypic
fractions of humanAML samples that were isolated
from engrafted mice. Each symbol represents
mean ± SD ofR 5mice; results were normalized to
the maximum TGR of that experiment.
(G) Dot plots show secondary engraftment levels
of AML cells that were recovered from primary
mice, sorted based on ATF4rep TGR, and re-
transplanted. Every dot represents median sec-
ondary engraftment (normalized to the average) of
one AML sample.
*p < 0.05, ****p < 0.0001. See also Figures S3
and S4.was increased compared to GFP-low cells. Using limiting dilu-
tion analysis, we calculated that the frequency of engrafting cells
was 1 in 19,804 cells in the GFP-high population and 1 in 71,922
cells in the GFP-low population; bulk TagBFP+ cells possessed
an intermediate HSC frequency of 1 in 41,046 cells (Figure 3E;
Figure S3C). Thus, cells that efficiently translate ATF4 are robust
and survive transplantation, indicating that high ISR activity
marks functional HSCs.
Enrichment of Human LSCs Based on High ISR Levels
The hierarchical structure of normal hematopoiesis is partially
maintained in acute myeloid leukemia (AML) and leukemia
stem cells (LSCs) that share numerous stemness properties
with normal HSCs are responsible for disease propagation
(Dick, 2008). We examined the expression of central ISR
components in AML cell populations. Similar to our findings
in normal CB cells, mass spectrometry revealed lower1114 Cell Reports 25, 1109–1117, October 30, 2018protein levels of eIF2a, eIF2b, and
eIF2g in phenotypically primitive (CD34+
CD38–) compared to differentiated(CD34+CD38+) AML cell populations (Figure 4A). Gene set
enrichment analysis of 54 ATF4 target genes showed enrich-
ment in primitive AML cells (Figure 4B). Similar trends were
observed when we compared functionally validated LSC+
versus LSC– populations for eIF2b and eIF2g protein detection
(Figure S3D) and ATF4 target mRNA expression (Figure S3E).
Low eIF2 levels and high ATF4 target gene expression sug-
gest that the high ISR activity we observed in normal HSC/
MPPs is conserved in LSCs.
To determine if ISR activity could be used to separate func-
tionally distinct AML cell populations, we examined ATF4rep
expression in human AML cells. Using the 8227 AML cell culture
system, which maintains hierarchical organization in vitro (Lech-
man et al., 2016), we found that primitive CD34+CD38– cells dis-
played the highest ATF4rep TGR, which progressively declined in
downstream progenitors (Figure 4C; Figure S3F). We sorted
GFP-high and GFP-low populations from ATF4rep-transduced
8227 AML cells and assessed culture-initiating capacity, a surro-
gate assay for LSC function. Only GFP-high cells were able to
expand in culture for over 3 weeks (Figure 4D), indicating that
ATF4rep activity can be used to prospectively isolate cells that
display features of primitive LSCs.
We wanted to evaluate ATF4rep expression in the malignant
hierarchy using primary AML patient samples. Since in vitro
expansion of primary AML cells is challenging and does not
maintain the developmental hierarchy, we transduced AML cells
with the ATF4rep and established AML in immunodeficient mice
(Figure 4E; Table S2). After 6–8 weeks, mice were sacrificed
and human AML cells were assessed for CD34/CD38 expression
and ATF4rep TGR by flow cytometry. In four out of five samples,
the ATF4rep TGR was higher in CD34+ compared to CD34– cells
(Figure 4F; Figure S4A). AML09191 was an exception, showing
higher ATF4rep TGR in CD34– compared to CD34+ cells. Taken
together, these ATF4rep measurements suggest that most pri-
mary AML samples have high ISR activity in phenotypically prim-
itive cells.
Although CD34 can enrich for LSCs in most AML cases, the
surface phenotype of AML cells can be decoupled from LSC ac-
tivity. To test whether primary AML cells that possess high ISR
activity are enriched for LSC function, we sorted TagBFP+
(bulk), GFP-low and GFP-high populations and transplanted
cells into secondary recipient mice (Figure 4E). GFP-high cells
showed higher engraftment in three out of eight samples, with
two additional samples showing the same trend (Figure S4B).
In AML09191, GFP-high cells showed higher engraftment, indi-
cating that ATF4rep activity maintained its correlation with LSC
activity despite its negative correlation with CD34 expression.
On average, GFP-high cells showed 8.5-fold higher secondary
engraftment than GFP-low cells (p < 0.0001; Figure 4G). These
data indicate that high ISR activity is associated with normal
and malignant stem cells.
DISCUSSION
Our data establish that the ISR-mediated pro-survival
program is uniquely wired in HSCs where it plays a role in
governing HSC function. The tendency of HSCs to undergo
apoptosis following stress and damage (Milyavsky et al.,
2010; van Galen et al., 2014a; Yahata et al., 2011) needs to
be balanced with alleviation of low-level perturbations that
occur under homeostasis to ensure HSC functionality. Our
results show that amino acid deprivation is one such perturba-
tion where ATF4-dependent pro-survival signals play a pro-
tective role. We show that high expression of the ISR effector
ATF4 is contingent on eIF2 scarcity, representing a mecha-
nism of ISR activity that may also safeguard stem cells in
other tissues (Blanco et al., 2016; Zismanov et al., 2016).
ATF4 is modulated by additional signals including mTOR
and post-translational modifications (Ben-Sahra et al., 2016;
Wortel et al., 2017). Several processes that are important for
HSC maintenance are regulated by ATF4, including auto-
phagy, amino acid metabolism and oxidative stress resistance
(B’chir et al., 2013; Harding et al., 2003; Ho et al., 2017; Taya
et al., 2016). Accordingly, ATF4-mediated reduction of oxida-
tive stress has been implicated to maintain erythropoiesis andHSC development in mice (Suragani et al., 2012; Zhao et al.,
2015). Additional studies are required to elucidate the full
complement of signals upstream and downstream of ATF4
in different conditions. In cancer, ATF4 has been shown to
confer resistance to nutrient deprivation, hypoxia, and ROS
(Rouschop et al., 2013; Ye et al., 2010). Considering the pro-
tective role of ATF4 for HSCs undergoing valine depletion,
AML therapies that affect amino acid metabolism should
take into account ATF4-dependent adaptive mechanisms
(Heydt et al., 2018; Jacque et al., 2015; Miraki-Moud et al.,
2015; Willems et al., 2013). The conservation of ISR signaling
in primitive CB and a subset of primary AML samples sup-
ports the possibility of targeting LSCs through the ISR
pathway and underscores the importance of monitoring adap-
tive responses in developmentally distinct cancer cell subpop-
ulations. Further evaluation of eIF2a phosphorylation and its
upstream kinases in activation of the ISR and how this is
differentially regulated in HSC and specific progenitor subsets
may inform strategies to modulate this pathway and stem cell
fate outcomes. Understanding the interplay between stem-
ness, translational control, and stress signaling is needed to
manipulate stem cells for therapeutic purposes, such as pro-
moting HSC survival during transplantation and gene therapy
or targeting the survival of LSCs.STAR+METHODS
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Phospho-eIF2a (Ser52) ThermoFisher Scientific Cat# 701268; RRID: AB_2532450
Rabbit monoclonal phospho-eIF2a (Ser51) ThermoFisher Scientific Cat# 44-728G; RRID: AB_10983400
ATF4-4 (D4B8) Rabbit monoclonal Cell Signaling Cat# 11815; RRID: AB_2616025
Rabbit monoclonal GAPDH (14C10) Cell Signaling Cat# 2118; RRID: AB_561053
PE-Cy7 Mouse Anti-Human CD38 (HB7) BD Cat# 335790
APC-Cy7 Mouse Anti-Human CD34 BD PharMingen Cat# 624072
APC Mouse Anti-Human CD45 (2D1) BD Cat# 340943
PE Mouse Anti-Human CD33 (P67.6) BD Cat# 347787
V450 Mouse Anti-Human CD7 (M-T701) BD Cat# 642916
PE Mouse Anti-Human CD19 (SJ25C1) BD Cat# 340364
PE-Cy5 Mouse Anti-Human CD90 BD PharMingen Cat# 555597
PE-Cy5 Mouse Anti-Human CD10 Beckman Coulter Cat# PN IM2721U
Biotin Mouse Anti-Human CD45RA BD PharMingen Cat# 555487
PE Mouse Anti-Human CD135 (FLT3) BD PharMingen Cat# 558996
PE-Cy5 Mouse Anti-Human CD49f BD PharMingen Cat# 551129
Biotin Mouse Anti-Human CD135 BD PharMingen Cat# 624008
Bacterial and Virus Strains
Vesicular Stomatitis virus G protein (VSVG) Addgene Plasmid# 14888
pMDLg/pRRE plasmid Addgene Plasmid# 60488
pRSV-Rev Addgene Plasmid# 12253
Biological Samples
Primary AML Patient Samples Princess Margaret Cancer Center
Healthy Human Umbilical Cord Blood
Donor
Trillium Health Partners
Healthy Human Umbilical Cord Blood
Donor
Credit Valley Hospital
Chemicals, Peptides, and Recombinant Proteins
Stem Cell Factor (SCF) Miltenyi Biotec Cat# 130-096-696
Fms-related tyrosine kinase ligand (FLT3-L) Miltenyi Biotec Cat# 130-096-474
Human Thrombopoietin (TPO) Miltenyi Biotec Cat# 130-095-752
Human Interleukin-6 (IL-6) Miltenyi Biotec Cat# 130-093-934
Human Granulocyte-Colony stimulating
factor (G-CSF)
Miltenyi Biotec Cat# 130-094-265
X-Vivo Chemically Defined Serum Lonza Cat# 04-380Q
Human Interleukin-3 (IL-3) Miltenyi Biotec Cat# 130-095-068
Iscove’s Modified Dulbecco’s Medium
(IMDM)
GIBCO Cat# 1240053
RIPA Buffer Thermo Fisher Cat# 899000
BCA Protein Assay Kit ThermoFisher Scientific Cat# 23225
Thapsigargin Sigma-Aldrich Cat# T9033
Cycloheximide Sigma-Aldrich Cat# C7698
Valproic Acid Sigma-Aldrich Cat# PHR1061
(Continued on next page)
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Bortezomib Cell Signaling Cat# 2204
Temsirolimus Sigma-Aldrich Cat# P20020
Anti-EIF2S1(phospho-S51) Abcam Cat# Ab32157; RRID: AB_732117
Critical Commercial Assays
Click-IT Plus EdU Pacific Blue Flow
Cytometry Kit
ThermoFisher Scientific Cat# 10636
Deposited Data
CB progenitor microarray Laurenti et al., 2013 GEO: GSE42414; Processed data, http://
jdstemcellresearch.ca/node/32
ATF4 targets Han et al., 2013
CB progenitor mass spectrometry E.M.S., S. Xie, A. Mitchell, K.B. Kaufmann,
Y. Ge, E. Lechman, T. Kislinger, B.T. Porse,
J.E.D., unpublished data
AML fractions RNA-seq Ng et al., 2016 GEO: GSE76009
Experimental Models: Cell Lines
TEX cells Dick lab, Princess Margaret Cancer Centre
8227 cells Dick lab, Princess Margaret Cancer Centre
MOLM13 DSMZ ACC 554
Experimental Models: Organisms/Strains
NOD/Lt-scid/IL2Rgnull (NSG) The Jackson Laboratory 005557
Oligonucleotides
See Table S3 for oligonucleotide
sequences.
Recombinant DNA
ATF4rep Dick lab, Princess Margaret Cancer Centre
ATF4.12rep Dick lab, Princess Margaret Cancer Centre
ATF4.14rep Dick lab, Princess Margaret Cancer Centre
eIF2aWT-OE Dick lab, Princess Margaret Cancer Centre
eIF2aS52A-OE Dick lab, Princess Margaret Cancer Centre
pLBC2 Dick lab, Princess Margaret Cancer Centre
Software and Algorithms
FACSDiva BD https://www.bdbiosciences.com/us/
instruments/research/software/c/2046610
FlowJo10 FlowJo, LLC https://www.flowjo.com/
Prism 7.0a GraphPad https://www.graphpad.com/
Extreme Limiting Dilution Analysis (ELDA) Hu and Smyth, 2009 http://bioinf.wehi.edu.au/software/elda/
Excel for Mac version 16.17 Microsoft https://www.microsoft.com/en-us/p/
excel-2016-for-mac/cfq7ttc0k5f2
RStudio Version 1.1.456 using R 3.5.1 RStudio https://www.rstudio.comCONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, John E.
Dick (John.Dick@uhnresearch.ca).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cord blood (CB) and acute myeloid leukemia (AML) samples
All human samples were obtainedwith informed consent according to procedures approved by the Institutional ReviewBoards of the
University Health Network, Trillium Hospital, and/or Credit Valley Hospital. Mononuclear cells were obtained by centrifugation of CB
on Ficoll (Ficoll-Paque Premium GE Healthcare) followed by red blood cell lysis with ammonium chloride solution (StemCellCell Reports 25, 1109–1117.e1–e5, October 30, 2018 e2
Technologies). Lineage depletion of mononuclear cells was achieved using StemSep Human Progenitor Cell Enrichment Kit accord-
ing to the manufacturer’s protocol (StemCell Technologies). Thawed Lin- CB cells were transduced as described previously (van Ga-
len et al., 2014b). Freshly thawed primary AML samples harvested from patients’ peripheral blood were exposed to lentivirus for
19 hours. Details of AML patient samples are outlined in Table S2.
CB, TEX, and 8227 cell preparation and liquid culture
Lineage depleted CB cells were stored in IMDMwith 50% FCS and 10%DMSO at150C until use. CB cells were expanded in vitro
in X-VIVO 10 (Bio Whittaker) supplemented with 1% BSA, 2 mM L-Glutamine, 100 U ml penicillin-streptomycin, and cytokines: SCF
(50ng/ml), G-CSF (5ng/ml), FLT3L (50ng/ml), TPO (7.5ng/ml) and IL-6 (5ng/ml). TLS-ERG-immortalized CB (TEX) cells were expanded
in IMDM with 15% FBS, 200mM L-glutamine, SCF (100ng/mL), IL-3 (10ng/mL) (Warner et al., 2005). The AML cell line 8227 was
cultured in X-Vivo media supplemented with cytokines as described (Lechman et al., 2016).
Mouse xenotransplantation
Animal work was carried out in accordance with guidelines approved by the University Health Network Animal Care Committee.
8-11 week-old male NOD/Lt-scid/IL2Rgnull (NSG) mice were sublethally irradiated (225 cGy using a 137Cs g-irradiator) 24h prior
to intrafemoral transplantation. CB cells were transduced, expanded in vitro for up to 4 days and injected into the right femur with
30 ml PBS (Figures 3B and 3C) or sorted into TagBFP+ (bulk), TagBFP+GFP-low and TagBFP+GFP-high populations and injected
at 10,000 or 30,000 cells per mouse (Figures 3D and 3E). Mice were euthanized after 8-11 weeks and the femurs were flushed
with PBS with 2% FCS. Cells were stained for surface markers and analyzed for TagBFP+CD45+ engraftment. Human engraftment
was scored as positive if themouse BMhad > 1%CD45+TagBFP+ cells. Primary AML samples were transduced overnight and trans-
planted at 100,000 or 300,000 cells permouse into the right femur with 30 ml PBS. After eight weeks, primarymicewere sacrificed and
their BM was analyzed by flow cytometry. To evaluate functional LSC content, pooled BM cells were sorted and transplanted into
secondary recipient mice at multiple cell doses. After 11 weeks, BM cells were analyzed by flow cytometry.
METHOD DETAILS
Lentiviral vectors
The ATF4 reporter was used as previously reported (van Galen et al., 2014a). Briefly, the plasmids ATF4.5: 50ATF4.GFP (Addgene
21852), ATF4.12: 50ATF4.uORF1AUA.GFP (Addgene 21859), and ATF4.14: 50ATF4.uORF1&2AUA.GFP (Addgene 21861) were used
to construct the bidirectional lentiviral reporter vectors ATF4rep, the negative control ATF4.12rep, and the positive control ATF4.14rep.
These three vectors are identical apart from uORF start codon mutations. For the ‘‘TagBFP only’’ control, luciferase was cloned
downstream of the SFFV promoter. We used the transgene ratio between GFP and TagBFP to account for differences in basal trans-
lation (TGR = GFPmean fluorescence intensity / TagBFP mean fluorescence intensity) as a measure of reporter activity. To generate
eIF2aS52A-OE, we mutated codon 52 from Serine to Alanine in EIF2S1 plasmid (Harvard plasmid clone HsCD00044214). Using Q5
Site-Directed mutagenesis kit (NEB E0554S) with mutagenic primers TAGTGAATTAGCCAGAAGGCG and AGAAGAATCATGCCTT
CAATG, the desired mutated eIF2aS52A was amplified and cloned downstream of the bidirectional minhCMV-SFFV promoter using
the Gateway compatible pLBC-OM-RFCA vector that also expresses mOrange.
shRNA knock-down constructs
shRNA sequences were predicted based on the Sherwood algorithm (Knott et al., 2014). shRNA oligo’s were ordered as Ultramers
from IDT and PCR amplified using AmpliTaq Gold 360 Polymerase (ThermoFisher) with shRNA amplification primers (Table S3). The
PCR product was subsequently digested with BamH1 and Mlu1 and cloned into the pLBC2 vector downstream of mCherry.
Quantitative PCR
Total RNA from cells was purified and DNase treated using the RNeasy Micro Kit (QIAGEN). RNA integrity was measured on the Agi-
lent Bioanalyzer (RNA nano kit, RNA integrity scores were > 9). cDNA was synthesized using SuperScript VILO cDNA Synthesis Kit
(ThermoFisher). Quantitative PCR analysis was performed on the LightCycler 480 Instrument II (Roche). All signals were quantified
using the DCt method and were normalized to the levels of GAPDH unless otherwise indicated. See Table S3 for primer sequences.
Amino acid depletion
AA depleted media were provided by Dr. Hiromitsu Nakauchi (Stanford University). CB cells were transduced with the ATF4 reporter.
After 24hrs, cells were washed and plated in various AA depleted conditions supplemented with 1% BSA, 100 U/ml penicillin-strep-
tomycin, and cytokines: SCF (50ng/ml), G-CSF (5ng/ml), Flt3L (50ng/ml), TPO (7.5ng/ml), IL-6 (5ng/ml), and IL3 (10ng/ml). After 48h
exposure to AA deficient media, cells were analyzed by flow cytometry.
Thapsigargin, cycloheximide, valproic acid, temsirolimus, and bortezomib
Compounds were purchased as follows: thapsigargin, Sigma-Aldrich, catalog number T9033; cycloheximide, Sigma-Aldrich,
catalog number C7698; valproic acid Sigma-Aldrich, PHR1061, bortezomib, Cell Signaling catalog number 2204; temsirolimus,e3 Cell Reports 25, 1109–1117.e1–e5, October 30, 2018
Sigma-Aldrich, catalog number PZ0020. All compoundswere resuspended in DMSOand stored at20Cuntil use. Final DMSOcon-
centration was% 1% in both control and treatments groups. Cell counts and viability analysis were carried out after 30h of drug treat-
ment and thapsigargin was used at 0.2 mM.
Mass spectrometry
CB cells were thawed through dropwise addition of 50%FBS, 50%X-vivo 10 and 1%DNase, washed, and stained for 30minutes on
ice either 1) with CD34 APC-Cy7 and CD38 PE-Cy7 at a 1:100 dilution to sort HSC/MPP versus progenitor cells, or 2) with CD45RA
BB515, CD90 PE, CD10 APC, CD7 V450 at 1:50, and CD34 APC-Cy7 and CD38 PE-Cy7 at 1:200 dilution to sort HSC, MPP,MLP and
GMP (Table S1). Equal amounts of sorted cells (100,000 for low-resolution sorts, 50,000 for high-resolution sorts) were processed for
mass spectrometry analysis as described (Lechman et al., 2016). Label-free quantitation was used to derive protein intensities and
resulting data was analyzed using MaxQuant (Cox et al., 2014; Cox and Mann, 2008). Protein quantities are shown in heatmaps of
log2 detection values. Values were centered by subtracting row means.
Fluorescence-Activated Cell Sorting (FACS) and intracellular flow cytometry
Immunophenotyping for human hematopoietic cell surface markers was carried out using the following antibodies: APC-conjugated
anti-CD45 (1:100 2D1), PE-conjugated anti-CD33 (1:100 P67.6) V450-conjugated anti-CD7 (1:50 M-T701), PE-Cy7-conjugated anti-
CD38 (1:100 HB7), APC-Cy7-conjugated anti-CD34, Biotin-conjugated anti-CD135 (1:50), PE-Cy5-conjugated anti-CD49f (1:100),
PE-conjugated anti-CD19 (1:100 SJ25C1), Biotin-conjugated anti-CD45RA (1:50), PE-Cy5 conjugated anti-CD90 (1:100). CB cells
were stained with antibodies for 30 min at 4C. FACS sorting was performed using FACSAria sorters, and FlowJo software was
used for data analysis.
For intracellular flow cytometry, CB cells were fixed with 80% methanol for 5 min, permeabilized with 0.1% PBS-Tween-20 for
30 min and incubated in PBS with 10% goat serum and 0.3M glycine. Cells were stained with primary antibody (total eIF2a: Santa
Cruz sc-133132, Phospho-eIF2a: Abcam 32157) for 30 min at room temperature and washed three times with PBS buffer by centri-
fugation at 300 g for 5 min each time. Secondary antibody (Alexa Fluor 488, Thermo Fisher Scientific A11034) was added to the cells
at 1:500 dilution for 30 min at room temperature, the cells were washed three times and resuspended in PBS buffer for analysis.
Apoptosis and cell proliferation assays
For the apoptosis assay, CB cells were washed with PBS and diluted in 1X Annexin V binding buffer to 1 3 106 in 0.5ml. Cells were
stained in Annexin V-FITC at room temperature in the dark for 15minutes. For the proliferation assay, CB cells were incubated at 37C
with 10mM of EdU for one hour. Cells were then fixed and permeabilized, and EdU incorporation into newly synthesized DNA was
detected using Pacific Blue Click-iT Plus EdU azide (ThermoFisher Scientific # C10636).
Immunofluorescence
CB cells were sorted based on CD34, CD38, and CD45RA. Cells were cytospun and fixed with 4% formaldehyde. Cells were then
blockedwith 1X PBSwith 5%normal serum and 0.3% Triton X-100 for 1h and stained with primary antibody for 1h (total eIF2a: Santa
Cruz sc-133132, Phospho-eIF2a: Thermo Fisher Scientific 701268). Fluorochrome-conjugated secondary antibodies (Alexa Fluor-
488 and Alexa Fluor-555) were applied for 1h. Coverslips were applied to slides with Prolong Gold Antifade Reagent with DAPI.
Images were obtained using an Olympus FluoView 1000 Laser Scanning Confocal Microscope and analyzed using Olympus Fluo-
view 1.1. Fluorochrome-specific signal intensity was quantified and normalized to cell areas selected from n = 8 images per stain.
Western blot
CD34+ CB cells were treated with 0.2 mM thapsigargin for 30 hours. GFP-low and GFP-high fractions were sorted and 50,000 cells
were lysed with RIPA buffer (Thermo Fisher Scientific 899000) containing protease and phosphatase inhibitors (Thermo Fisher Sci-
entific 78446). Samples were centrifuged at 12,000 g for 5 min at 4C and supernatants were used in western assay. Protein concen-
tration was measured by BCA protein assay (Thermo Fisher Scientific 23225). Western size assay was performed with ProteinSimple
Wes separation instrument. Samples were prepared and resolved on the 12-230 kDa capillary cartridge according to manufacturer’s
instructions. Antibodies (Cell Signaling anti-ATF4 #11815 and anti-GAPDH #2118) were titrated on a lysate fromCD34+ CB cells prior
to the experiment to determine the optimal dilutions, which was 1:5 for ATF4 and 1:200 for GAPDH (capillary western uses very
concentrated samples requiring higher antibody concentrations than regular western blot). Note that we used a monoclonal C-ter-
minal antibody that does not overlap with the ATF4-GFP fusion gene in the ATF4rep vector (Cell Signaling #11815).
Transcriptional analysis
Expression levels of ATF4 and ATF4 target genes were assessed in CB microarray datasets that were previously reported (Laurenti
et al., 2013). To display ATF4 expression, the log2 values of three probes were corrected (by adding 1.87,2.43 and 0.56) to equalize
each HSC1 value to the mean HSC1 value across the three probes (Figure 1E). To determine expression of ATF4 targets in CB
progenitors, we started from a list of target genes that was previously defined by ER stress induction in mouse embryo fibroblasts
followed by ATF4 and CHOP ChIP-seq and RNA-seq (Han et al., 2013). Considering our specific interest in ATF4, we only assessed
254 ATF4-specific target genes (Overlap: ATF4 ONLY), and not CHOP (103) or common (218) targets. Gene symbol conversion usingCell Reports 25, 1109–1117.e1–e5, October 30, 2018 e4
BioMart identified 225 human homologs. Of these 225 genes, we found that 54 were differentially expressed in HSC/MPPs (HSC1,
HSC2 and MPP) compared to myeloid progenitors (CMP, GMP, and MEP, p < 0.01 by Student’s t test) in previously reported micro-
arrays (Laurenti et al., 2013). These 54 genes are shown in a heatmap (log2, and centered expression values) and used for GSEA (Fig-
ures 1F, 1G, and 4B).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical details are provided in the figure legends. Unless otherwise noted, mean ± standard deviation values are given and
P values are calculated by two-tailed unpaired Student’s t test using Microsoft Excel (version 16.17). To compare engraftment levels,
we performed Mann–Whitney U-tests, as these data do not show a normal distribution, using Prism software (version 7.0a;
GraphPad). To analyze in vivo limiting dilution analysis, we used ELDA software (Hu and Smyth, 2009) (http://bioinf.wehi.edu.au/
software/elda). For heatmaps of mRNA and protein expression, expression values from microarrays or MaxQuant were log2 trans-
formed, centered, and visualized using the image function and a blue to white to red color gradient using R statistical software
(RStudio Version 1.1.456). Stars are used to indicate significance in the figures: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.
DATA AND SOFTWARE AVAILABILITY
The accession number for previously reported microarrays of CB progenitors is GEO: GSE42414 (Laurenti et al., 2013). The acces-
sion number for previously reported RNA-seq of AML fraction is GEO: GSE76009 (Ng et al., 2016). Mass spectrometry analysis of
hematopoietic progenitor cells is in preparation for publication (E.M.S., S. Xie, A. Mitchell, K.B. Kaufmann, Y. Ge, E. Lechman, T. Ki-
slinger, B.T. Porse, J.E.D., unpublished data).e5 Cell Reports 25, 1109–1117.e1–e5, October 30, 2018
